Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Finward Bancorp FNWD Stock Month Start Institutional Selling 20260415 AISP Airship AI shares rise despite 443 earnings miss and 335 revenue decline puzzling investors News Analysis This startup built Japans first 3Dprinted twostory home It wants to solve th JLS Nuveen quarterly earnings metrics remain undisclosed investors pause trades ahead of official management commentary What is dragging RadNet RDNT stock lower Q4 2025 Profit Surprises Is now a good time to buy Voyager VACHU stock today Vanguard Emerging Markets Stock Index Fund VWO Neutral 2026 Suitability Assessment for NonUS Equity Allocations Bain Cap GSS BCSS Flat at 1018 Consolidation Continues 20260515 Banzai BNZI Q1 2026 Disappoints EPS 994 Below 694 Views OFS Credit OCCIO Q1 2026 Earnings Miss EPS 076 vs 022 Expected Odysightai ODYS Q2 2025 Results Miss Estimates EPS 025 vs 012 Graham Corporation GHM Stock Today Drops 153 Key Support at 8830 20260519 OneIM OIMAW Stock Up 328 Key Resistance at 066 20260517 Egypts Landmark Gas Discoveries Signal Upstream Revival Yet Import Challenges Remain Five Childrens Toys Sold in Britain Found to Contain Asbestos Guardian Investigation Reveals Microsofts GitHub Faces Reliability Challenges as Competition Intensifies in AI Coding Race Chinese Investors Flock to Dividend Stocks Amid Market Uncertainty Ebola Outbreak in DRC Raises Concerns Over Healthcare Resources and Regional Economic Stability Peloton Interactive Goldman Sachs Raises Price Target on Fitness Stock Amid Improved Guidance TMO Q1 2026 Earnings EPS Surpasses Estimates by 284 Stock Edges Down DCTH Q1 2026 Earnings Narrowed Loss Beats Expectations Amid Strategic Progress BBB Foods Inc TBBB Q1 2026 Earnings EPS Misses Estimates Stock Rises on Operational Progress Privia Health Group Q1 2026 Earnings EPS Miss Amid Margin Pressures Upstream Bio UPB Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Edges Lower ONCY Q3 2025 Earnings Clinical Progress Overshadows WiderThanExpected Loss Serina Therapeutics SER Faces Selling Pressure Tests Key Support Levels X4 Pharmaceuticals XFOR Gains 273 as Stock Tests Key Resistance Levels NovoCure NVCR Holds Steady With Modest Gains Testing Key Levels American Electric Power AEP Advances 153 as Utility Sector Holds Steady Biodexa Pharmaceuticals BDRX Extends Gains Testing Key Resistance at 344 Blue Origins New Glenn Rocket Explodes During Ground Test Marks Setback for Jeff Bezos Space Venture Huaweis Hers Law Challenge How Sanctions Are Driving Tech Innovation The Federal Reserves Current Challenges Policy Constraints and Economic Uncertainty Novartis Raises FullYear Outlook on Strong Operational Performance Urea and DAP Fertiliser Sales Surge in MarchMay Amid West Asia Tensions Government Assures Adequate Kharif Stocks Biotech Sector in Focus Morningstar Highlights Potential Opportunities Surge in AI Chip Demand Propels SK Hynix and Micron into TrillionDollar Valuation Club Ashok Leyland Sees Resilient CV Demand Cycle Despite Fuel Price Volatility Shenu Agarwal Hedge Funds Eye SmallCap Biotech Potential Opportunities in Emerging Therapeutics